ProQR Therapeutics N.V.
ProQR Therapeutics N.V.（PRQR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
prqr · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$5.00
Consensus
$3.63
+137.3% upside
Low
$2.00
Median: $3.75 · Last Close: $1.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.63
137.3% upside
High Target
$5
226.8%
Low Target
$2
30.7%
Current Price
$1.53
as of today
Based on analyst price targets, the PRQR stock price prediction for the next 12 months ranges from $2 to $5. The consensus PRQR price forecast of $3.63 implies 137.3% upside from the current price of $1.53.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.50 | ↓ 1.66% |
1-day model range: $1.49–$1.52. Peak: $1.52 (-1.66%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PRQR · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-04 | Chardan Capital | Maintains | Buy→Buy |
| 2025-08-08 | Chardan Capital | Maintains | Buy→Buy |
| 2025-06-27 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-06-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-05-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-03-14 | Chardan Capital | Maintains | Buy→Buy |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-12 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-12-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ProQR Therapeutics N.V. (PRQR) stock. Of the recent 47 rating actions, 4 were upgrades and 2 were downgrades. 10 analysts currently cover PRQR.
分析师推荐趋势
PRQR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$21M
↓ 64.8% YoY
Revenue Next Year
$17M
↓ 18.6% YoY
EPS This Year
$-0.52
EPS Next Year
$-0.60
↑ 15.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast PRQR EPS of $-0.52 for the current fiscal year, based on estimates from 4 analysts. The PRQR revenue forecast is $21M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PRQR 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PRQR 的共识目标价为 $3.63（+137.3% 上行空间），分析师共识为 Buy。
PRQR 的短期预测（明日）为 $1.50（-1.66%）。 PRQR 对 2027 年的股价预测均值为 $1。 PRQR 对 2030 年的预测区间为 $0–$1。
ProQR Therapeutics N.V. 在 NASDAQ 上市，代码 PRQR。PRQR 在 2027 年的整体展望偏积极，在覆盖分析师中约 90% 对应 Buy 共识。
常见问题
PRQR 预测 · 8 个问题根据 10 位华尔街分析师，PRQR 的 12 个月平均目标价为 $3.63，最高 $5.00、最低 $2.00。若有图表，中位目标价可在上方查看。相对当前价 $1.53，隐含约 +137.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.